US Patent 9822353 PEGylated aspartyl-tRNA synthetase polypeptides
Patent 9822353 was granted and assigned to aTyr Pharma on November, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9822353 PEGylated aspartyl-tRNA synthetase polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.